Načítá se...
Structural modification of DNA—a therapeutic option in SLE?
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organs, with glomerulonephritis representing a frequent and serious manifestation. SLE is characterized by the presence of various autoantibodies, including anti-DNA antibodies that occur in approximately 70% of patien...
Uloženo v:
| Vydáno v: | Nat Rev Rheumatol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4745409/ https://ncbi.nlm.nih.gov/pubmed/22009329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrrheum.2011.153 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|